Rob Mason

“I was hoping you could contextualize the orders a little finer. I think coming into the quarter, you know, the thought was maybe the book-to-bill would be closer to one, and you clearly outperformed that.”

“My question is just around capital allocation, if there's been any change in the thought process for 2026. I think originally you were earmarked about half the free cash flow for the year towards share repurchase?”

“Just as a follow-up, within the 10 businesses, since they went into private equity, how has the leadership been, I guess, has there been much leadership turnover since they've been owned by private equity at the top?”

“In fact, Rich, I'll offer my congrats on passing the baton there as well.”

“I think, you know, you made comment, Matthias, just around the robustness of the M&A pipeline And, you know, the capital raise kind of signaled that as well. You know, as you think about your areas of priority, you know, it seems like you're biased to medical.”